Skip to search formSkip to main contentSkip to account menu

2,3-dinor-6-ketoprostaglandin F1alpha

Known as: Pgi2-M, 2,3-Dkpgf1alpha, Cyclopentanepentanoic Acid, 3,5-Dihydroxy-2-((1E,3S)-3-Hydroxy-1-Octenyl)-Gamma-Oxo-, (1R,2R,3R,5S)- 
A beta-oxidation product of 6-keto prostaglandin F1 alpha (PGF1a) and the major urinary metabolite of prostaglandin I2 (prostacyclin, PGI2). 2,3… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Background—Atherosclerosis has features of an inflammatory disease. Because cyclooxygenase (COX)-2 is expressed in… 
Highly Cited
2002
Highly Cited
2002
Cyclooxygenase-2 (COX-2) is known to mediate the cardioprotective effects of the late phase of ischemic preconditioning (PC… 
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To determine CSF eicosanoid concentrations and brain cyclo-oxygenase activity in AD patients and age-matched control… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND Prostaglandin play a pivotal role in spinal nociceptive processing. At therapeutic concentrations, acetaminophen is… 
Highly Cited
1998
Highly Cited
1998
Prostacyclin (prostaglandin I2, PGI2) has a variety of functions, including inhibition of smooth muscle cell proliferation… 
Highly Cited
1997
Highly Cited
1997
Early pregnancies in women with a history of recurrent spontaneous abortion (RSA) are accompanied by a deficiency in vasodilatory… 
Highly Cited
1978
Highly Cited
1978
The effects of the newly discovered bicyclic prostaglandin, prostacyclin (PGI2), on the pulmonary and systemic vascular beds were… 
Highly Cited
1976